Quantitative cell signaling analysis for cetuximab sensitivity prediction in colorectal cancer

被引：0
|
作者：
Teppei, Matsuo
Nishizuka, Satoshi
Lwaya, Takeshi
Ishida, Kazushige
Noda, Hironobu
Ikeda, Miyuki
Kozai, Megumi
Wakabayashi, Go
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-4146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4146
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cetuximab Sensitivity Associated with Oxaliplatin Resistance in Colorectal Cancer
    Ekblad, Lars
    Johnsson, Anders
    ANTICANCER RESEARCH, 2012, 32 (03) : 783 - 786
  • [2] CETUXIMAB AND IRINOTECAN IN METASTATIC COLORECTAL CANCER, DRUG RESPONSE AND ITS PREDICTION: RETROSPECTIVE ANALYSIS
    Nemecek, R.
    Kocakova, I
    Kocak, I
    Svoboda, M.
    Lakomy, R.
    Poprach, A.
    Slaby, O.
    Nenutil, R.
    Tucek, S.
    Vyzula, R.
    ANNALS OF ONCOLOGY, 2009, 20 : 71 - 71
  • [3] A proteomics analysis of cell signaling alterations in colorectal cancer
    Madoz-Gurpide, Juan
    Canamero, Marta
    Sanchez, Lydia
    Solano, Jose
    Alfonso, Patricia
    Casal, J. Ignacio
    MOLECULAR & CELLULAR PROTEOMICS, 2007, 6 (12) : 2150 - 2164
  • [4] Cetuximab for colorectal cancer
    Fraggetta, Filippo
    Pelosi, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11): : 1196 - 1196
  • [5] Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer
    Yu, Chaoran
    Hong, Hiju
    Lu, Jiaoyang
    Zhao, Xuan
    Hu, Wenjun
    Zhang, Sen
    Zong, Yaping
    Mao, Zhihai
    Li, Jianwen
    Wang, Mingliang
    Feng, Bo
    Sun, Jing
    Zheng, Minhua
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [6] Additional value of EGFR downstream signaling phosphoprotein expression to KRAS mutation for response prediction to cetuximab in colorectal cancer (CRC)
    Merlin, J. L.
    Perkins, G.
    Lievre, A.
    Ramacci, C.
    Emile, J. F.
    Boige, V.
    Bibeau, F.
    Bouche, O.
    Penault-Llorca, F.
    Laurent-Puig, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Cetuximab in the management of colorectal cancer
    Lenz, Heinz-Josef
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (02): : 77 - 91
  • [8] Cetuximab for metastatic colorectal cancer
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2007, 8 (08): : 673 - 673
  • [9] Cetuximab in metastatic colorectal cancer
    Broadbridge, Vy Tuong
    Karapetis, Cristos S.
    Price, Timothy Jay
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (05) : 555 - 565
  • [10] Cetuximab for the treatment of colorectal cancer
    Jonker, Derek J.
    O'Callaghan, Chris J.
    Karapetis, Christos S.
    Zalcberg, John R.
    Tu, Dongsheng
    Au, Heather-Jane
    Berry, Scott R.
    Krahn, Marianne
    Price, Timothy
    Simes, R. John
    Tebbutt, Niall C.
    van Hazel, Guy
    Wierzbicki, Rafal
    Langer, Christiane
    Moore, Malcolm J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20): : 2040 - 2048
12345